From RTT News:

Bristol-Myers Squibb Co. released its financial results for Q4, initiating adjusted earnings and revenue growth guidance for full-year 2024. The company projects adjusted earnings of $7.10 to $7.40 per share and global revenue growth in the low single-digits for fiscal 2024. Q4 net income was $1.76 billion, with adjusted net earnings per share at $1.70. Total revenues for the quarter declined 1% to $11.48 billion. Analysts expected Q4 earnings of $1.53 per share on revenues of $11.19 billion.



Read more: Bristol-Myers Squibb Guides FY24 Adj. EPS Above Estimates As Q4 Results Top Estimates